CJ Bioscience, Inc. (KOSDAQ: 311690)
South Korea
· Delayed Price · Currency is KRW 9,740.00
0.00 (0.00%)
Jan 21, 2025, 9:15 AM KST
CJ Bioscience Revenue
CJ Bioscience had revenue of 744.19M KRW in the quarter ending September 30, 2024, a decrease of -55.60%. This brings the company's revenue in the last twelve months to 3.97B, down -29.25% year-over-year. In the year 2023, CJ Bioscience had annual revenue of 5.58B with 36.82% growth.
Revenue (ttm)
3.97B
Revenue Growth
-29.25%
P/S Ratio
21.77
Revenue / Employee
n/a
Employees
n/a
Market Cap
123.73B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 5.58B | 1.50B | 36.82% |
| Dec 31, 2022 | 4.07B | -288.37M | -6.61% |
| Dec 31, 2021 | 4.36B | -948.52M | -17.86% |
| Dec 31, 2020 | 5.31B | 528.32M | 11.05% |
| Dec 31, 2019 | 4.78B | 859.18M | 21.90% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 292.86T |
| SK hynix | 57.73T |
| LG Energy Solution | 27.17T |
| Samsung Biologics Co.,Ltd. | 4,364.39B |
| Hyundai Motor Company | 170.28T |
| Kia Corporation | 104.63T |
| Celltrion | 2,876.25B |
| KB Financial Group | 14.11T |